胰腺β细胞特异性SCD1过表达通过维持代谢应激下功能性β细胞量改善葡萄糖稳态
本研究探讨硬脂酰辅酶A去饱和酶1(SCD1)在稳定β细胞MafA表达与活性中的作用。在2型糖尿病患者胰岛、db/db小鼠及高脂饮食诱导糖尿病小鼠中SCD1表达降低;β细胞特异性Scd1敲入小鼠在高脂饮食模型中胰岛素缺乏、糖耐量异常及β细胞去分化/转分化均改善。机制上SCD1直接结合E3泛素连接酶HRD1,阻断MafA-HRD1相互作用而稳定核内MafA;SCD酶反应产物(主要为油酸)还缓解高糖毒性介导的氧化应激。
要点
- 2型糖尿病患者、db/db小鼠及高脂饮食小鼠β细胞SCD1表达较健康对照降低。
- β细胞特异性Scd1敲入改善高脂饮食糖尿病小鼠的胰岛素缺乏与糖耐量异常。
- SCD1通过结合HRD1阻断MafA泛素化降解,并以去饱和酶依赖和非依赖方式稳定MafA。
核心结论
- SCD1以去饱和酶依赖和非依赖两种方式稳定β细胞MafA,从而在代谢应激下改善葡萄糖稳态。
- 该研究为糖尿病精准医学治疗提供了潜在的新靶点。
研究设计与样本
- 分析2型糖尿病患者胰岛、高血糖db/db小鼠及高脂饮食诱导糖尿病小鼠模型中SCD1表达水平。
- 构建胰腺β细胞特异性Scd1敲入(βSCD1KI)小鼠研究SCD1对β细胞功能与身份的作用。
- 在MIN6和HEK293A细胞中检测SCD1与MafA的蛋白-蛋白相互作用。
- 采用染色质免疫沉淀、基于细胞的泛素化实验及脂肪酸组成分析探究分子机制。
主要发现
- 与健康对照相比,2型糖尿病患者β细胞及高脂饮食喂养和db/db小鼠β细胞中SCD1表达降低,归因于高糖毒性诱导的Scd1启动子组蛋白去乙酰化。
- β细胞SCD1功能获得改善高脂饮食诱导糖尿病小鼠的胰岛素缺乏、糖耐量异常及β细胞去分化/转分化。
- 在小鼠胰岛和MIN6细胞中,SCD1直接结合E3泛素连接酶HRD1,通过干扰MafA-HRD1相互作用稳定核内MafA,抑制泛素化介导的MafA降解。
- SCD酶反应产物(主要为油酸)在MIN6细胞中缓解高糖毒性介导的氧化应激。
临床怎么用
- 原文结论指出SCD1为糖尿病精准医学治疗提供了潜在新靶点,未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The key pancreatic beta cell transcription factor v-maf musculoaponeurotic fibrosarcoma oncogene homologue A (MafA) is critical for the maintenance of mature beta cell function and phenotype. The expression levels and/or activities of MafA are reduced when beta cells are chronically exposed to diabetogenic stress, such as hyperglycaemia (i.e. glucotoxicity). Interventional targets and adjuvant therapies to abate MafA loss in beta cells may provide evidence to support the effective treatment of diabetes. In this study, we aimed to investigate the function of stearoyl-CoA desaturase 1 (SCD1) in the stabilisation of MafA expression and activity in order to maintain functional beta cell mass, with a view to suppressing the development of type 2 diabetes. METHODS: SCD1 expression levels were analysed in islets obtained from humans with type 2 diabetes, hyperglycaemic db/db mice, and a high-fat diet (HFD)-induced mouse model of diabetes. Pancreatic beta cell-specific Scd1 knockin (βSCD1KI) mice were generated to study the role of SCD1 in beta cell function and identity. The protein-to-protein interactions between SCD1 and MafA were detected in MIN6 and HEK293A cells. We used experiments including chromatin immunoprecipitation, cell-based ubiquitination assay and fatty acid composition analysis to investigate the specific molecular mechanism underlying the effect of SCD1 on the restoration of MafA and beta cell function under glucotoxic conditions. RESULTS: SCD1 expression was reduced in beta cells of humans with type 2 diabetes and in HFD-fed and db/db mice compared with healthy controls, which was attributed to glucotoxicity-induced Scd1 promoter histone deacetylation. Gain-of-function of SCD1 in beta cells improved insulin deficiency, glucose intolerance and beta cell dedifferentiation/transdifferentiation in the HFD-induced mouse model of diabetes. Mechanistically, SCD1 directly bound to the E3 ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) and stabilised nuclear MafA through interrupting MafA-HRD1 interactions in mouse islets and MIN6 cells, which inhibited the ubiquitination-mediated degradation of MafA. Moreover, the products of SCD enzyme reactions (mainly oleic acid) also alleviated glucotoxicity-mediated oxidative stress in MIN6 cells. CONCLUSIONS/INTERPRETATION: Our findings indicate that SCD1 stabilises beta cell MafA both in desaturase-dependent and -independent manners, thus improving glucose homeostasis under metabolic stress. This provides a potential novel target for precision medicine for the treatment of diabetes.
引用
- Yin W, Zou S, Sha M, et al. Gain of pancreatic beta cell-specific SCD1 improves glucose homeostasis by maintaining functional beta cell mass under metabolic stress. Diabetologia. 2024. PMID: 39690249. doi:10.1007/s00125-024-06343-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。